Interleukin-17A
| GO Term |
|---|
| extracellular region |
| extracellular space |
| external side of plasma membrane |
| GO Term |
|---|
| cytokine activity |
| protein homodimerization activity |
| protein heterodimerization activity |
| Pathway Name | Organism |
|---|---|
| Interleukin-17 signaling | Homo sapiens |
| Interleukin-4 and Interleukin-13 signaling | Homo sapiens |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12361 | Graves' disease | |
| DOID:13375 | temporal arteritis | |
| DOID:2755 | Mycobacterium avium complex disease | |
| DOID:2841 | asthma | |
| DOID:2942 | bronchiolitis | |
| DOID:4448 | macular degeneration | |
| DOID:4481 | allergic rhinitis | |
| DOID:4483 | rhinitis | |
| DOID:7147 | ankylosing spondylitis | |
| DOID:7148 | rheumatoid arthritis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025